BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/10/2026 7:08:44 AM | Browse: 21 | Download: 99
 |
Received |
|
2025-11-03 08:05 |
|
Peer-Review Started |
|
2025-11-03 08:07 |
|
First Decision by Editorial Office Director |
|
2025-11-10 07:04 |
|
Return for Revision |
|
2025-11-10 07:04 |
|
Revised |
|
2025-11-17 13:39 |
|
Publication Fee Transferred |
|
2025-11-18 10:13 |
|
Second Decision by Editor |
|
2026-01-09 02:42 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-09 14:12 |
|
Articles in Press |
|
2026-01-09 14:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-30 09:44 |
|
Publish the Manuscript Online |
|
2026-04-10 07:08 |
| ISSN |
2218-5836 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Basic Study |
| Article Title |
Xianling Gubao capsule alleviates osteoporosis: Modulation of gut-bone axis and Wnt signaling
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ao-Xue Yu, Wei-Hui Liang, Ya-Shuang Zhou, Pan Li, Jia-Mei Ji, Feng-Wei Zhang, Peng Yu and Jia Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Science and Technology Department of Jilin Province - Jilin Provincial Science and Technology Development Plan Project |
20250204060YY |
|
| Corresponding Author |
Jia Liu, PhD, Office of Scientific Research, Changchun University of Chinese Medicine, No. 1035 Boshuo Road, Jingyue National High-tech Industrial Development Zone, Changchun 130117, Jilin Province, China. ccliujia1002@126.com |
| Key Words |
Osteoporosis; Xianling Gubao capsule; Gut microbiota; Ovariectomized rats; Wnt/β-catenin |
| Core Tip |
This study demonstrates that the Xianling Gubao capsule (XLGB) alleviates osteoporosis by modulating the gut-bone axis. Utilizing a multi-omics approach, we reveal that XLGB not only improves bone microstructure and serum bone markers but also rectifies ovariectomy-induced gut microbiota dysbiosis and metabolic disturbances. More importantly, we identify that its core mechanism involves the activation of the osteogenic Wnt/β-catenin pathway while simultaneously suppressing the adipogenic peroxisome proliferator-activated receptor gamma pathway, thereby rebalancing osteogenic-adipogenic differentiation in the bone marrow. This provides a novel mechanistic basis for XLGB’s anti-osteoporotic effects and underscores the gut-bone axis as a promising therapeutic target. |
| Publish Date |
2026-04-10 07:08 |
| Citation |
Yu AX, Liang WH, Zhou YS, Li P, Ji JM, Zhang FW, Yu P, Liu J. Xianling Gubao capsule alleviates osteoporosis: Modulation of gut-bone axis and Wnt signaling. World J Orthop 2026; 17(4): 116046 |
| URL |
https://www.wjgnet.com/2218-5836/full/v17/i4/116046.htm |
| DOI |
https://dx.doi.org/10.5312/wjo.v17.i4.116046 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
